Wikisage, the free encyclopedia of the second generation, is digital heritage

Fabry disease: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 11: Line 11:


[https://link.springer.com/article/10.1007%2Fs12551-018-0432-5 Anderson-Fabry disease in heart failure]
[https://link.springer.com/article/10.1007%2Fs12551-018-0432-5 Anderson-Fabry disease in heart failure]
Galafold [summary of product characteristics]. Buckinghamshire, UK; Amicus Therapeutics UK Ltd: 2017
<references/>
<references/>

Revision as of 00:49, 11 August 2018

Fabry disease is a genetic condition involving lysosomal storage (E75.2)[1]is an X-linked disorder caused by alpha-galactosidase A deficiency [2]

migalastat or 1-deoxygalactonojirimycin received an orphan drug approval [3]

  • improves diarrhea

https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0813-7 Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY


Anderson-Fabry disease in heart failure

Galafold [summary of product characteristics]. Buckinghamshire, UK; Amicus Therapeutics UK Ltd: 2017